Radiopharmaceuticals in Nuclear Medicine Market Report

Radiopharmaceuticals in Nuclear Medicine Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Oct 10, 2019
  • PAGES：170
  • REPORT CODE：GMM310865
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Radiopharmaceuticals in Nuclear Medicine market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.0% during the forecast period.

    This report presents the market size and development trends by detailing the Radiopharmaceuticals in Nuclear Medicine market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Radiopharmaceuticals in Nuclear Medicine market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Radiopharmaceuticals in Nuclear Medicine industry and will help you to build a panoramic view of the industrial development.

    Radiopharmaceuticals in Nuclear Medicine Market, By Type:

    • Diagnostic

    • Therapeutic

    Radiopharmaceuticals in Nuclear Medicine Market, By Application:

    • Oncology

    • Cardiology

    • Neurology

    • Thyroid

    • Others

    Some of the leading players are as follows:

    • Siemens AG

    • Jubilant Life science

    • Fujifilm Holding Corporation

    • Isotec, Inc (Sigma-Aldrich).

    • Mallinckrodt plc

    • Board of Radiation And Isotope Technology (BRIT).

    • Bayer AG

    • Lantheus Medical Imaging

    • Cardinal Health

    • Novartis International AG (Advanced accelerator)

    • General Electric Co. (healthcare division)

    • Medtronic, Inc.

    • IBA Group

    • Curium Pharma

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Radiopharmaceuticals in Nuclear Medicine Market: Technology Type Analysis

    • 4.1 Radiopharmaceuticals in Nuclear Medicine Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Radiopharmaceuticals in Nuclear Medicine Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Diagnostic

      • 4.3.2 Therapeutic

    5 Radiopharmaceuticals in Nuclear Medicine Market: Product Analysis

    • 5.1 Radiopharmaceuticals in Nuclear Medicine Product Market Share Analysis, 2018 & 2026

    • 5.2 Radiopharmaceuticals in Nuclear Medicine Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Radiopharmaceuticals in Nuclear Medicine Market: Application Analysis

    • 6.1 Radiopharmaceuticals in Nuclear Medicine Application Market Share Analysis, 2018 & 2026

    • 6.2 Radiopharmaceuticals in Nuclear Medicine Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Oncology

      • 6.3.2 Cardiology

      • 6.3.3 Neurology

      • 6.3.4 Thyroid

      • 6.3.5 Others

    7 Radiopharmaceuticals in Nuclear Medicine Market: Regional Analysis

    • 7.1 Radiopharmaceuticals in Nuclear Medicine Regional Market Share Analysis, 2018 & 2026

    • 7.2 Radiopharmaceuticals in Nuclear Medicine Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Siemens AG

      • 9.1.1 Siemens AG Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Jubilant Life science

      • 9.2.1 Jubilant Life science Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Fujifilm Holding Corporation

      • 9.3.1 Fujifilm Holding Corporation Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Isotec, Inc (Sigma-Aldrich).

      • 9.4.1 Isotec, Inc (Sigma-Aldrich). Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Mallinckrodt plc

      • 9.5.1 Mallinckrodt plc Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Board of Radiation And Isotope Technology (BRIT).

      • 9.6.1 Board of Radiation And Isotope Technology (BRIT). Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 Bayer AG

      • 9.7.1 Bayer AG Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 Lantheus Medical Imaging

      • 9.8.1 Lantheus Medical Imaging Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 Cardinal Health

      • 9.9.1 Cardinal Health Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

    • 9.10 Novartis International AG (Advanced accelerator)

      • 9.10.1 Novartis International AG (Advanced accelerator) Company overview

      • 9.10.2 Financial performance

      • 9.10.3 Product benchmarking

      • 9.10.4 Strategic initiatives

      • 9.10.5 SWOT analysis

    • 9.11 General Electric Co. (healthcare division)

      • 9.11.1 General Electric Co. (healthcare division) Company overview

      • 9.11.2 Financial performance

      • 9.11.3 Product benchmarking

      • 9.11.4 Strategic initiatives

      • 9.11.5 SWOT analysis

    • 9.12 Medtronic, Inc.

      • 9.12.1 Medtronic, Inc. Company overview

      • 9.12.2 Financial performance

      • 9.12.3 Product benchmarking

      • 9.12.4 Strategic initiatives

      • 9.12.5 SWOT analysis

    • 9.13 IBA Group

      • 9.13.1 IBA Group Company overview

      • 9.13.2 Financial performance

      • 9.13.3 Product benchmarking

      • 9.13.4 Strategic initiatives

      • 9.13.5 SWOT analysis

    • 9.14 Curium Pharma

      • 9.14.1 Curium Pharma Company overview

      • 9.14.2 Financial performance

      • 9.14.3 Product benchmarking

      • 9.14.4 Strategic initiatives

      • 9.14.5 SWOT analysis

     

    The List of Tables and Figures (Totals 84 Figures and 161 Tables)

    • Figure Diagnostic Radiopharmaceuticals in Nuclear Medicine market, 2015 - 2026 (USD Million)

    • Figure Therapeutic Radiopharmaceuticals in Nuclear Medicine market, 2015 - 2026 (USD Million)

    • Figure Oncology market, 2015 - 2026 (USD Million)

    • Figure Cardiology market, 2015 - 2026 (USD Million)

    • Figure Neurology market, 2015 - 2026 (USD Million)

    • Figure Thyroid market, 2015 - 2026 (USD Million)

    • Figure Others market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Radiopharmaceuticals in Nuclear Medicine market, by country, 2015 - 2026 (USD Million)

    • Table North America Radiopharmaceuticals in Nuclear Medicine market, by type, 2015 - 2026 (USD Million)

    • Table North America Radiopharmaceuticals in Nuclear Medicine market, by product, 2015 - 2026 (USD Million)

    • Table North America Radiopharmaceuticals in Nuclear Medicine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Radiopharmaceuticals in Nuclear Medicine market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Radiopharmaceuticals in Nuclear Medicine market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Radiopharmaceuticals in Nuclear Medicine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Radiopharmaceuticals in Nuclear Medicine market, by type, 2015 - 2026 (USD Million)

    • Table Canada Radiopharmaceuticals in Nuclear Medicine market, by product, 2015 - 2026 (USD Million)

    • Table Canada Radiopharmaceuticals in Nuclear Medicine market, by application, 2015 - 2026 (USD Million)

    • Table Europe Radiopharmaceuticals in Nuclear Medicine market, by country, 2015 - 2026 (USD Million)

    • Table Europe Radiopharmaceuticals in Nuclear Medicine market, by type, 2015 - 2026 (USD Million)

    • Table Europe Radiopharmaceuticals in Nuclear Medicine market, by product, 2015 - 2026 (USD Million)

    • Table Europe Radiopharmaceuticals in Nuclear Medicine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Radiopharmaceuticals in Nuclear Medicine market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Radiopharmaceuticals in Nuclear Medicine market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Radiopharmaceuticals in Nuclear Medicine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Radiopharmaceuticals in Nuclear Medicine market, by type, 2015 - 2026 (USD Million)

    • Table Germany Radiopharmaceuticals in Nuclear Medicine market, by product, 2015 - 2026 (USD Million)

    • Table Germany Radiopharmaceuticals in Nuclear Medicine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Radiopharmaceuticals in Nuclear Medicine market, by type, 2015 - 2026 (USD Million)

    • Table France Radiopharmaceuticals in Nuclear Medicine market, by product, 2015 - 2026 (USD Million)

    • Table France Radiopharmaceuticals in Nuclear Medicine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Radiopharmaceuticals in Nuclear Medicine market, by type, 2015 - 2026 (USD Million)

    • Table Italy Radiopharmaceuticals in Nuclear Medicine market, by product, 2015 - 2026 (USD Million)

    • Table Italy Radiopharmaceuticals in Nuclear Medicine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Radiopharmaceuticals in Nuclear Medicine market, by type, 2015 - 2026 (USD Million)

    • Table Spain Radiopharmaceuticals in Nuclear Medicine market, by product, 2015 - 2026 (USD Million)

    • Table Spain Radiopharmaceuticals in Nuclear Medicine market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Radiopharmaceuticals in Nuclear Medicine market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Radiopharmaceuticals in Nuclear Medicine market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Radiopharmaceuticals in Nuclear Medicine market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Radiopharmaceuticals in Nuclear Medicine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Radiopharmaceuticals in Nuclear Medicine market, by type, 2015 - 2026 (USD Million)

    • Table China Radiopharmaceuticals in Nuclear Medicine market, by product, 2015 - 2026 (USD Million)

    • Table China Radiopharmaceuticals in Nuclear Medicine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Radiopharmaceuticals in Nuclear Medicine market, by type, 2015 - 2026 (USD Million)

    • Table Japan Radiopharmaceuticals in Nuclear Medicine market, by product, 2015 - 2026 (USD Million)

    • Table Japan Radiopharmaceuticals in Nuclear Medicine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Radiopharmaceuticals in Nuclear Medicine market, by type, 2015 - 2026 (USD Million)

    • Table India Radiopharmaceuticals in Nuclear Medicine market, by product, 2015 - 2026 (USD Million)

    • Table India Radiopharmaceuticals in Nuclear Medicine market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Radiopharmaceuticals in Nuclear Medicine market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Radiopharmaceuticals in Nuclear Medicine market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Radiopharmaceuticals in Nuclear Medicine market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Radiopharmaceuticals in Nuclear Medicine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Radiopharmaceuticals in Nuclear Medicine market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Radiopharmaceuticals in Nuclear Medicine market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Radiopharmaceuticals in Nuclear Medicine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Radiopharmaceuticals in Nuclear Medicine market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Radiopharmaceuticals in Nuclear Medicine market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Radiopharmaceuticals in Nuclear Medicine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Radiopharmaceuticals in Nuclear Medicine market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Radiopharmaceuticals in Nuclear Medicine market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Radiopharmaceuticals in Nuclear Medicine market, by application, 2015 - 2026 (USD Million)

    • Table MEA Radiopharmaceuticals in Nuclear Medicine market, by country, 2015 - 2026 (USD Million)

    • Table MEA Radiopharmaceuticals in Nuclear Medicine market, by type, 2015 - 2026 (USD Million)

    • Table MEA Radiopharmaceuticals in Nuclear Medicine market, by product, 2015 - 2026 (USD Million)

    • Table MEA Radiopharmaceuticals in Nuclear Medicine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Radiopharmaceuticals in Nuclear Medicine market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Radiopharmaceuticals in Nuclear Medicine market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Radiopharmaceuticals in Nuclear Medicine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Radiopharmaceuticals in Nuclear Medicine market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Radiopharmaceuticals in Nuclear Medicine market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Radiopharmaceuticals in Nuclear Medicine market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Siemens AG Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Jubilant Life science Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Fujifilm Holding Corporation Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Isotec, Inc (Sigma-Aldrich). Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Mallinckrodt plc Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Board of Radiation And Isotope Technology (BRIT). Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Bayer AG Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Lantheus Medical Imaging Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Cardinal Health Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Novartis International AG (Advanced accelerator) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table General Electric Co. (healthcare division) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Medtronic, Inc. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table IBA Group Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Curium Pharma Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US